Eleutherococcus Species Cultivated in Europe: A New Source of Compounds with Antiacetylcholinesterase, Antihyaluronidase, Anti-DPPH, and Cytotoxic Activities

Table 2

Optimized LC-MS (MRM) parameters for all analytes. Compounds confirmed by comparison with authentic standards.

Compound	Retention time (min)	Q1 ()	Q3 ()	DP^a (V)	EP^b (V)	CEP^c (V)	CE^d (eV)	CXP^e (eV)
Gallic acid	1.01	168.7	178.9; 124.9	-35; -35	-3; -3	-12; -12	-36; -14	0; 0
Protocatechuic acid	2.16	152.9	80.9; 107.8	-55; -55	-1; -1	-10; -10	-26; -38	0; 0
Gentisic acid	3.32	352.9	80; 96.9	-70; -70	-4; -4	-16; -16	-110; -52	0; 0
4-OH-benzoic acid	4.25	136.8	92.9	-30	-7	-10	-18	0
Vanillic acid	5.51	166.8	107.9; 123	-35; -35	-4; -4	-12; -12	-18; -12	0; 0
Caffeic acid	5.69	178.7	88.9; 134.9	-30; -30	-6.5; -6.5	-12; -12	-46; -16	0; 0
Syringic acid	6.34	196.9	122.8; 181.9	-30; -30	-9; -9	-12; -12	-24; -12	0; -2
p-Coumaric acid	6.67	162.8	93; 119	-30; -30	-8; -8	-12; -12	-44; -14	0; 0
Ferulic acid	6.83	192.8	133.9; 177.9	-25; -25	-11.5; -11.5	-14; -14	-16; -12	0; -2
Salicylic acid	6.86	136.9	75; 93	-35; -35	-4; -4	-10; -10	-48; -16	0; -2
Veratric acid	6.88	180.7	121.9; 136.9	-35; -35	-6; -6	-14; -14	-18; -12	0; 0
Sinapic acid	6.88	222.8	121; 148.9	-35; -35	-8.5; -8.5	-10; -10	-36; -20	0; 0
m-Coumaric acid	6.89	162.8	91; 119	-35; -35	-4.5; -4.5	-12; -12	-36; -14	0; 0
Rosmarinic acid	7.01	358.7	132.6; 160.8	-50; -50	-5; -5	-26; -26	-44; -20	0; -2

^aDP: declustering potential; ^bEP: entrance potential; ^cCEP: cell entrance potential; ^dCE: collision energy; ^eCXP: collision cell exit potential.